DE602004030015D1 - Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten - Google Patents

Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten

Info

Publication number
DE602004030015D1
DE602004030015D1 DE602004030015T DE602004030015T DE602004030015D1 DE 602004030015 D1 DE602004030015 D1 DE 602004030015D1 DE 602004030015 T DE602004030015 T DE 602004030015T DE 602004030015 T DE602004030015 T DE 602004030015T DE 602004030015 D1 DE602004030015 D1 DE 602004030015D1
Authority
DE
Germany
Prior art keywords
mixtures
manufacture
pharmaceutical compositions
compositions containing
derived oligosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004030015T
Other languages
English (en)
Inventor
Volker Laux
Pierre Mourier
Christian Viskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE602004030015D1 publication Critical patent/DE602004030015D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE602004030015T 2003-07-24 2004-07-22 Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten Active DE602004030015D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309041A FR2857971B1 (fr) 2003-07-24 2003-07-24 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2004/001943 WO2005010051A2 (fr) 2003-07-24 2004-07-22 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DE602004030015D1 true DE602004030015D1 (de) 2010-12-23

Family

ID=33561051

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030015T Active DE602004030015D1 (de) 2003-07-24 2004-07-22 Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten

Country Status (40)

Country Link
EP (1) EP1651677B1 (de)
JP (1) JP4865552B2 (de)
KR (1) KR101125517B1 (de)
CN (1) CN1852926B (de)
AR (1) AR045917A1 (de)
AT (1) ATE487741T1 (de)
AU (1) AU2004259111B2 (de)
BR (1) BRPI0412850A (de)
CA (1) CA2533555A1 (de)
CR (1) CR8201A (de)
CY (1) CY1111165T1 (de)
DE (1) DE602004030015D1 (de)
DK (1) DK1651677T3 (de)
EC (1) ECSP066305A (de)
ES (1) ES2355827T3 (de)
FR (1) FR2857971B1 (de)
GT (1) GT200400145A (de)
HK (1) HK1094806A1 (de)
HN (1) HN2004000250A (de)
IL (1) IL173206A (de)
MA (1) MA27928A1 (de)
ME (1) MEP11608A (de)
MX (1) MXPA06000336A (de)
MY (1) MY136769A (de)
NO (1) NO20060821L (de)
NZ (1) NZ544717A (de)
OA (1) OA13197A (de)
PA (1) PA8606801A1 (de)
PE (1) PE20050246A1 (de)
PL (1) PL1651677T3 (de)
PT (1) PT1651677E (de)
RS (1) RS20060044A (de)
RU (1) RU2346005C2 (de)
SI (1) SI1651677T1 (de)
TN (1) TNSN06025A1 (de)
TW (1) TWI369208B (de)
UA (1) UA89356C2 (de)
UY (1) UY28435A1 (de)
WO (1) WO2005010051A2 (de)
ZA (1) ZA200600657B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589145B2 (en) 2004-04-15 2009-09-15 Exxonmobil Chemical Patents Inc. Syndiotactic rich polyolefins
EP2404939A3 (de) * 2006-05-25 2012-03-21 Momenta Pharmaceuticals, Inc. Heparinzusammensetzung mit geringem Molekulargewicht und Anwendungen dafür
CN101711771B (zh) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制法和药物组合物
KR101847846B1 (ko) * 2010-09-14 2018-04-11 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 고순도 헤파린 및 그 제조방법
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
CN102558392A (zh) * 2010-12-14 2012-07-11 王芃 一种高抗FXa、低抗FIIa低分子肝素钠的制备方法
CN102816255B (zh) * 2011-06-10 2015-11-25 王芃 一种超低分子肝素钠的制备方法
WO2014153995A1 (zh) * 2013-03-26 2014-10-02 中国科学院昆明植物研究所 一种低分子量糖胺聚糖衍生物及其药物组合物和其制备方法与应用
CN103864959A (zh) * 2014-04-03 2014-06-18 中国药科大学 一种肝素十二糖抗动脉粥样硬化的用途
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
WO1998055515A1 (en) * 1997-06-06 1998-12-10 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
FR2807043B1 (fr) * 2000-03-28 2002-11-22 Aventis Pharma Sa Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
CA2458852A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
KR20060059974A (ko) 2006-06-02
ATE487741T1 (de) 2010-11-15
AU2004259111B2 (en) 2009-06-11
UA89356C2 (ru) 2010-01-25
MA27928A1 (fr) 2006-06-01
PL1651677T3 (pl) 2011-04-29
BRPI0412850A (pt) 2006-10-03
PE20050246A1 (es) 2005-06-02
RU2346005C2 (ru) 2009-02-10
CY1111165T1 (el) 2015-06-11
AR045917A1 (es) 2005-11-16
PT1651677E (pt) 2011-02-08
CN1852926B (zh) 2010-05-12
ECSP066305A (es) 2006-07-28
WO2005010051A2 (fr) 2005-02-03
MXPA06000336A (es) 2006-03-30
ZA200600657B (en) 2007-05-30
PA8606801A1 (es) 2005-02-04
SI1651677T1 (sl) 2011-03-31
EP1651677A2 (de) 2006-05-03
NO20060821L (no) 2006-04-20
GT200400145A (es) 2005-03-16
CA2533555A1 (fr) 2005-02-03
KR101125517B1 (ko) 2012-03-23
CN1852926A (zh) 2006-10-25
JP2006528614A (ja) 2006-12-21
FR2857971B1 (fr) 2005-08-26
HN2004000250A (es) 2006-06-29
HK1094806A1 (en) 2007-04-13
RU2006105384A (ru) 2007-09-10
OA13197A (fr) 2006-12-13
NZ544717A (en) 2009-09-25
FR2857971A1 (fr) 2005-01-28
RS20060044A (en) 2008-06-05
CR8201A (es) 2006-09-22
MEP11608A (en) 2010-06-10
TW200522970A (en) 2005-07-16
WO2005010051A3 (fr) 2005-06-16
MY136769A (en) 2008-11-28
TNSN06025A1 (en) 2007-10-03
UY28435A1 (es) 2005-02-28
EP1651677B1 (de) 2010-11-10
IL173206A (en) 2010-11-30
AU2004259111A1 (en) 2005-02-03
TWI369208B (en) 2012-08-01
DK1651677T3 (da) 2011-02-28
JP4865552B2 (ja) 2012-02-01
ES2355827T3 (es) 2011-03-31
IL173206A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
FR2842201B1 (fr) Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
ATE522560T1 (de) Bluttherapiebehälter, die polyesterzusammensetzungen aus 2,2,4,4- tetramethylcyclobutandiol und 1,4- cyclohexandimethanol enthalten
ATE432919T1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE60237269D1 (de) Kosmetische Zusammensetzungen, die Aminosilikone und Verdickungsmittel enthalten, und deren Verwendungen
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
EE200400059A (et) Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
IL220888A0 (en) 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
FR2843023B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
IL174647A (en) Pyrazolopyridines and analogs thereof, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
DE60122567D1 (de) Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
DE60219051D1 (de) Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
DE60209779D1 (de) Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
ATE470679T1 (de) Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
NO20042158L (no) Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme
ATE433750T1 (de) Zusammensetzungen, die combretastatin und krebsbekämpfendes mittel enthalten
DE602004020907D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
DE502004000891D1 (de) Organosilylfunktionalisierte partikel und deren herstellung
DE602004030015D1 (de) Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
IL173004A0 (en) Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments